Assessments of Prostate Cancer Cell Functions Highlight Differences Between a Pan‐pi3k/mtor Inhibitor, Gedatolisib, and Single‐node Inhibitors of the PI3K/AKT/mTOR Pathway

Adrish Sen,Salmaan Khan,Stefano Rossetti,Aaron Broege,Ian Macneil, Ann DeLaForest,Jhomary Molden, Laura Davis, Charles Iversrud, Megan Seibel, Ross Kopher, Stephen Schulz,Lance Laing

Molecular oncology（2024）

Cited 2|Views4

Key words

gedatolisib,inhibitors,PI3K/AKT/mTOR pathway,prostate cancer

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined